3779 results for «2022»

Filter By

3779 results

Elixir medical strengthens its commercial capabilities with the addition of Alaeddin Ahram as executive vice president, International

24 Mar 2022

Vesalio Announces the Completion of Enrollment in Its FDA IDE Clinical Study for Acute Ischemic Stroke

11 May 2022

TAVI sessions from EuroPCR 2025 : Abbott

19 Jun 2025

Watch these recordings from EuroPCR 2025 on TAVI.

TAVI sessions from EuroPCR 2025: Abbott

CATHI Joins with VSS to Launch World’s First Online Training Program for Endovascular Simulation

13 May 2022

Bentley launched its first product in the United States

18 May 2023

Biosensors International Announces Japanese PMDA Approval for BioFreedom™ Ultra and US FDA Approval for BioFreedom™

03 May 2022

The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

05 Sep 2023

The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Lucas Lauder

Author

Lucas Lauder

Author

Felix Mahfoud
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

BIOSOLVE-IV full-cohort two-year data confirm excellent safety and efficacy profile of Magmaris resorbable magnesium scaffold

23 Sep 2022

MedAlliance announces enrollment of over 1,660 patients in landmark SELUTION DeNovo study

14 Sep 2023

15-month results of the MASTER DAPT trial

01 Sep 2022

Alex Sticchi provides his take on the final results of the MAnagement of high bleeding risk patients post bioresorbable polymer coated STEnt implantion with an abbReviated versus prolonged DAPT regimen

Alessandro Sticchi

Author

Alessandro Sticchi
15-month results of the MASTER DAPT trial

The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

01 Sep 2022

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Alessandro Sticchi

Author

Alessandro Sticchi
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

How to perform angiographic check after large-sheath removal in single access procedures

18 Mar 2024

In the absence of other arterial access, this step-by-step tutorial shows how to perform anterograde angiography of the arterial axis after removal of the large sheath, making it easier to recognise and rapidly manage vascular complications such as arterial lesions and haemostasis failure.

Francesco Burzotta

Author

Francesco Burzotta
Lazzaro Paraggio

Author

Lazzaro Paraggio
Mattia Lunardi

Author

Mattia Lunardi
Cristina Aurigemma

Author

Cristina Aurigemma
Enrico Romagnoli

Author

Enrico Romagnoli

Author

Francesco Fracassi

Author

Antonino Buffon
C. Trani

Author

Carlo Trani
How to perform angiographic check after large-sheath removal in single access procedures

Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty

18 May 2022

Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis

24 Jun 2024

Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.

Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis

EDIT-CMD trial results: edifying our approach to patients with ANOCA

03 Apr 2022

Dejan Milasinovic provides his take on the EDIT-CMD Randomized Clinical Trial which aimed to assess the efficacy of diltiazem to improve coronary vasomotor dysfunction in angina and nonobstructive coronary arteries.

Dejan Milasinovic

Author

Dejan Milasinovic
Results of the EDIT-CMD Randomized Clinical Trial: Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in Angina and Nonobstructive Coronary Arteries

No go (again) for oral anticoagulation after TAVR: Results of the ADAPT-TAVR trial

04 Apr 2022

Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.

Francesco Costa

Author

Francesco Costa
A Randomized ADAPT-TAVR Trial: Edoxaban Vs DAPT For Valve Thrombosis and Cerebral Thromboembolism After TAVR

MedAlliance Acquires Japanese Partner MDK Medical

02 Feb 2022

Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out

14 Nov 2023

Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.

Luis Ortega-Paz

Author

Luis Ortega-Paz
DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes

MedAlliance enrolls first US patient into its third FDA IDE Study: SFA SELUTION4SFA

04 May 2023

FDA approves US oriented clinical study of Bentley’s BeGraft and Cook’s Zenith® Fenestrated+ Endovascular Graft for treatment of aortic aneurysms CAUTION: Investigational device. Limited by United States law to investigational use.

28 Jun 2023

Didn’t find what you were looking for?